Concepedia

YC Chan

YC

Statistics

Publications

3

Citations

251

H-Index

3

Active since

2016

Affiliations

University of Oxford(Current)

YC Chan is an author at University of Oxford specializing in medicine, chronic kidney disease progression prevention, and renal disease.

Publications per year

2016–2023

3

Publications

3

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

Surgical management of carotid body tumor – Is Shamblin classification sufficient to predict surgical outcome?

Yuk Law, YC Chan, SW Cheng · Vascular · 2016 · 53 citations

, , +9

1–3 of 3